Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DSM-Firmenich AGDSMFF 58 Debt-to-Equity is 0.29 as of Dec. 2025, which is 21% above its 10-year median of 0.24. GuruFocus rates DSMFF with a GF Score™ of 58/100 and a GF Value™ of $89.10 (Fairly Valued). The stock has 8 warning signs investors should review. Among 1,420 Chemicals companies, DSM-Firmenich AG ranks better than 55.7% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for DSM-Firmenich AG's Debt-to-Equity or its related term are showing as below:
DSMFF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.21 Med: 0.24 Max: 0.29
Current: 0.29
During the past 4 years, the highest Debt-to-Equity Ratio of DSM-Firmenich AG was 0.29. The lowest was 0.21. And the median was 0.24.
DSMFF's Debt-to-Equity is ranked better than 55.7% of 1420
companies
in the Chemicals industry
Industry Median: 0.36
vs DSMFF: 0.29
DSM-Firmenich AG (OTCPK:DSMFF) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
DSM-Firmenich AG Debt-to-Equity Related Terms
DSM-Firmenich AG Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for DSM-Firmenich AG's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, DSM-Firmenich AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG Debt-to-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG (DSMFF) has a Debt-to-Equity of 0.29 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on DSM-Firmenich AG and its competitors. This is 21% above median its historical median of 0.24. Over the past decade, DSM-Firmenich AG's Debt-to-Equity has ranged from 0.21 to 0.29. According to the industry distribution chart, DSM-Firmenich AG ranks #629 out of 1420 companies in the Chemicals industry, placing it in the top 44.3%.
Is DSM-Firmenich AG's Debt-to-Equity too high?
DSM-Firmenich AG's current Debt-to-Equity of 0.29 is 21% above median its 10-year median of 0.24. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 0.29. The Chemicals industry median Debt-to-Equity is 0.36. DSM-Firmenich AG's value of 0.29 is 19.4% below this industry median. Based on the distribution chart, DSM-Firmenich AG ranks #629 out of 1420 companies in the Chemicals industry, which is above the industry midpoint. Overall, DSM-Firmenich AG has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's Debt-to-Equity compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #629 out of 1420 companies for Debt-to-Equity. This puts DSM-Firmenich AG in the upper half of its industry. The industry median Debt-to-Equity is 0.36. DSM-Firmenich AG's value of 0.29 is 19.4% below this benchmark. Historically, DSM-Firmenich AG's own Debt-to-Equity has ranged from 0.21 to 0.29 over the past decade. While the company's 10-year median is 0.24 vs. the industry median of 0.36, DSM-Firmenich AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Chemicals company?
The median Debt-to-Equity among Chemicals companies is 0.36, based on 1,420 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DSM-Firmenich AG's current Debt-to-Equity of 0.29 is 19.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on DSM-Firmenich AG and its competitors. For the Chemicals industry, the median Debt-to-Equity is 0.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current Debt-to-Equity is 0.29, which is 21% above median its own 10-year median of 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (DSMFF) is currently considered Fairly Valued. The stock's GF Value™ is $89.10, compared to a current price of $91.31 — trading 2.5% above its estimated fair value. The current Debt-to-Equity is 0.29, which is 21% above median its 10-year median of 0.24 and 19.4% below the Chemicals industry median of 0.36. DSM-Firmenich AG's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For DSM-Firmenich AG (DSMFF), the current Debt-to-Equity is 0.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (DSMFF) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of $91.31 is trading 2.5% above its estimated GF Value™ of $89.10.
GuruFocus considers DSM-Firmenich AG to be Fairly Valued.
Key valuation signals for DSMFF:
Debt-to-Equity: 0.29 (21% above median its 10-year median of 0.24)
GF Value™: $89.10 vs. price of $91.31 (2.5% above fair value)
Industry Position: 19.4% below the Chemicals median (#629 of 1420)
No single metric tells the full story. See the DSMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
58GF Score
Get the complete analysis for DSMFF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DSMFF has been successfully added to your 
